Profil
Boris Minev formerly worked at Genelux Corp., as Director-Immunotherapy &Translational Oncology from 2010 to 2015, UCSD Moores Cancer Center, as Director-Tumor Immunology & Immunotherap from 2000 to 2015, and Calidi Biotherapeutics, Inc., as Chief Medical Officer & President-Medical Affairs from 2015 to 2025.
Dr. Minev received his doctorate degree from Medical University Sofia.
Anciens postes connus de Boris Minev
| Sociétés | Poste | Fin |
|---|---|---|
| CALIDI BIOTHERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 29/07/2025 |
| GENELUX CORPORATION | Corporate Officer/Principal | 01/06/2015 |
UCSD Moores Cancer Center
UCSD Moores Cancer Center Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical research services for cancer treatment | Corporate Officer/Principal | 01/06/2015 |
Formation de Boris Minev
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Genelux Corp.
Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
UCSD Moores Cancer Center
UCSD Moores Cancer Center Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical research services for cancer treatment | Commercial Services |
Medical University Sofia
Medical University Sofia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies which attacks solid tumors | Health Technology |
















